EUR-Lex Access to European Union law

Back to EUR-Lex homepage

This document is an excerpt from the EUR-Lex website

Document 62023TB1182

Case T-1182/23 R: Order of the President of the General Court of 29 February 2024 – Neuraxpharm Pharmaceuticals v Commission

OJ C, C/2024/2628, 22.4.2024, ELI: http://data.europa.eu/eli/C/2024/2628/oj (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)

ELI: http://data.europa.eu/eli/C/2024/2628/oj

European flag

Official Journal
of the European Union

EN

C series


C/2024/2628

22.4.2024

Order of the President of the General Court of 29 February 2024 – Neuraxpharm Pharmaceuticals v Commission

(Case T-1182/23 R)

(Interim relief - Medicinal products for human use - Marketing authorisation for ‘Dimethyl fumarate Neuraxpharm - dimethyl fumarate’ - Application for suspension of operation of a measure - No urgency)

(C/2024/2628)

Language of the case: English

Parties

Applicant: Neuraxpharm Pharmaceuticals, SL (Barcelona, Spain) (represented by: K. Roox, T. De Meese, J. Stuyck and C. Dumont, lawyers)

Defendant: European Commission (represented by: A. Spina and E. Mathieu, acting as Agents)

Re:

By its application based on Articles 278 and 279 TFEU, the applicant seeks suspension of the operation of Commission Implementing Decision C(2023) 8921 final of 13 December 2023 revoking Commission Implementing Decision C(2022) 3254 final of 13 May 2022 granting marketing authorisation under Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Union procedures for the authorisation and supervision of medicinal products for human use and establishing a European Medicines Agency (OJ 2004 L 136, p. 1), as amended, for ‘Dimethyl fumarate Neuraxpharm – dimethyl fumarate’, a medicinal product for human use.

Operative part of the order

1.

The application for interim relief is refused.

2.

The costs are reserved.


ELI: http://data.europa.eu/eli/C/2024/2628/oj

ISSN 1977-091X (electronic edition)


Top